GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Northland Biotech Co Ltd (BJSE:430047) » Definitions » Total Equity

Beijing Northland Biotech Co (BJSE:430047) Total Equity : ¥409.09 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Northland Biotech Co Total Equity?

Beijing Northland Biotech Co's total equity for the quarter that ended in Mar. 2024 was ¥409.09 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Beijing Northland Biotech Co Total Equity Historical Data

The historical data trend for Beijing Northland Biotech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Northland Biotech Co Total Equity Chart

Beijing Northland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.27 314.38 279.83 239.06 196.62

Beijing Northland Biotech Co Quarterly Data
Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 227.14 221.78 211.12 196.62 409.09

Beijing Northland Biotech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Beijing Northland Biotech Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=328.121-131.497
=196.62

Beijing Northland Biotech Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=510.822-101.732
=409.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Northland Biotech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Beijing Northland Biotech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Northland Biotech Co (BJSE:430047) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Shangdi Kaikai Road, A406, Zhongguancun Biomedical Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Beijing Northland Biotech Co (BJSE:430047) Headlines

No Headlines